论文部分内容阅读
目的观察健宝灵颗粒治疗小儿脾胃不和型厌食症的临床疗效。方法将123例脾胃不和型厌食症患儿随机分为2组,对照组61例给予多潘立酮片治疗,治疗组62例给予健宝灵颗粒治疗,4周为1个疗程,连续治疗2个疗程后比较2组的临床疗效以及2组治疗前后的体质量、进食量、血红蛋白含量及血锌含量。结果治疗组总有效率为88.7%,对照组为73.8%,2组比较差异有统计意义(P<0.05)。2组治疗后体质量稍有增加,但同组治疗前后及治疗后2组比较,差异均无统计意义(P>0.05);治疗后2组进食量均显著增加,血锌含量均显著升高(P<0.05或P<0.01),且治疗组改善程度显著高于对照组(P<0.05);治疗组治疗后血红蛋白显著升高(P<0.05),且显著高于对照组(P<0.05)。结论健宝灵颗粒治疗小儿脾胃不和型厌食症疗效显著,且无明显不良反应,值得临床推广应用。
Objective To observe the clinical efficacy of Jianbao ling in treating children with spleen and stomach anorexia. Methods One hundred and twenty-three children with anorexia of spleen and stomach syndrome were randomly divided into two groups. The control group received Domperidone treatment. Sixty-two cases were given Jianbaoling granule treatment. Four weeks were a course of treatment. Two courses of continuous treatment After comparing the clinical efficacy of two groups and before and after treatment in two groups of body weight, food intake, hemoglobin content and blood zinc content. Results The total effective rate was 88.7% in the treatment group and 73.8% in the control group. There was significant difference between the two groups (P <0.05). After treatment, the body weight increased slightly in both groups, but there was no significant difference between the two groups before and after treatment and after treatment (P> 0.05). After treatment, the food intake of both groups increased significantly and the content of blood zinc increased significantly (P <0.05 or P <0.01), and the improvement in the treatment group was significantly higher than that in the control group (P <0.05). The hemoglobin of the treatment group was significantly higher than that of the control group (P <0.05) ). Conclusion JianBaoLing granule treatment of children with anorexia of spleen and stomachAnd a significant effect, and no significant adverse reactions, is worthy of clinical application.